Ophthalmic formulations of squalamine

• 收藏
• 分享

专利权人:

Ohr Pharmaceutical; Inc

发明人:

Taraporewala, Irach B.,Backenroth, Samuel I.

申请号：

AU2015258244

公开号：

AU2015258244C1

申请日:

2015.11.19

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

#$%^&*AU2015258244C120161103.pdf#####OPHTHALMIC FORMULATIONS OF SQUALAMINE Abstract The invention relates to ophthalmic formulations of squalamine or its pharmaceutically acceptable salts for the treatment of conditions of the eye such as, for example, wet age-related macular degeneration (wet AMD), choroidal neovascularization, retinopathy, dry age-related macular degeneration (dry AMD), polypoidal choroidal vasculopathy, neovascularization following ocular surgery, macular edema, retinal venous occlusion, subchoroidal neovascularization, retinal epithelial detachment, pterygum or foveal geographic atrophy of the retinal pigment epithelium.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/